Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Combining ESWT and Blood Flow Restriction Therapy for Lateral Epicondylitis

Official title: The Effects Of Combining Blood Flow Restriction Therapy With Extracorporeal Shock Wave Therapy On Pain, Muscle Strength, And Functional Outcomes İn Patients Diagnosed With Lateral Epicondylitis: a Randomized Controlled Trial

Run by Ankara Yildirim Beyazıt University · NCT07782723 · Data updated 2026-11-12

This study tests whether combining extracorporeal shock wave therapy (ESWT) with blood flow restriction (BFR) therapy helps people with lateral epicondylitis restore function and reduce pain.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment52 (estimated)
SponsorAnkara Yildirim Beyazıt University
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedApril 3, 2025
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedOctober 28, 2026
Trial IDNCT07782723 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–60 with a clinician-confirmed diagnosis of lateral epicondylitis and meeting BMI criteria who volunteer for the study.

Probably not a fit

Individuals with other elbow pathologies, prior elbow surgery, significant comorbidities, or contraindications to ESWT or BFR may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines the effects of combining extracorporeal shock wave therapy (ESWT) with blood flow restriction (BFR) therapy in adults aged 18–60 with lateral epicondylitis. Participants will receive both treatments to see if the combination provides greater pain relief and functional improvement than either approach alone. The trial will monitor safety and tolerability, as well as measures of grip strength and elbow function. The hypothesis is that dual-modality therapy may enhance tissue healing and functional outcomes through complementary mechanisms. No phase designation is listed for this study.

Why it matters

Potential benefit: If successful, participants may experience reduced elbow pain and improved grip strength and function.

How similar studies have gone: There is currently no published study combining ESWT with BFR for lateral epicondylitis, making this a novel approach with uncertain prior outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Having been diagnosed with lateral epicondylitis by a specialist physician
2. Being between the ages of 18 and 60
3. Having a body mass index (BMI) between normal weight (18.5-24.9 kg/m²) and overweight (25.0-29.9 kg/m²)
4. Volunteering to participate in the study

Exclusion Criteria:

1. Presence of a different elbow pathology
2. Presence of bilateral lateral epicondylitis
3. Presence of sensory and motor impairments in the upper extremities
4. History of surgery in the elbow region
5. History of systemic or metabolic disease
6. History of diabetes mellitus
7. History of hematological disease
8. History of cardiac disease, heart failure, or coronary artery disease
9. History of hypertension
10. Malignancy
11. History of peripheral vascular disease (presence of varicose veins/history, history of deep vein thrombosis, presence of lymphedema)
12. Coagulation disorder
13. Use of anticoagulants
14. History of pulmonary disease
15. History of pulmonary embolism
16. Pregnancy
17. Use of oral contraceptives
18. Patients with a pacemaker
19. History of trauma to the upper extremity within the past 6 months or 1 year

Where it's running

  • Gülhane Training and Research Hospital, Clinic of Sports Medicine
    Ankara, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.